MedPath
NMPA Approval

Rivaroxaban Tablets

国药准字H20247123

June 7, 2024

国药准字H20213398

Drug Information

利伐沙班片

片剂

2.5mg

化学药品

June 7, 2024

Company Information

Applicant Company

苏州市吴江区汾湖高新技术产业开发区金字路8号

Manufacturing Company

苏州市吴江区汾湖高新技术产业开发区金字路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利伐沙班片 - NMPA 批准文号 | MedPath